Unipolar Depression

Neurology
2
Pipeline Programs
3
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
1
KetaminePhase 42 trials
Active Trials
NCT01881763Completed31Est. Jul 2017
NCT01349231Completed10Est. Dec 2011
Soterix Medical
Soterix MedicalNJ - Woodbridge
2 programs
1
Soterix Medical mini-CT tDCS stimulatorPhase 11 trial
transcranial direct current stimulationN/A1 trial
Active Trials
NCT07042217RecruitingEst. Sep 2026
NCT04781127CompletedEst. Aug 2022
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) ScaleN/A1 trial
Active Trials
NCT01360307Completed330Est. Nov 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsKetamine
Alliance PharmaceuticalsKetamine
Soterix MedicalSoterix Medical mini-CT tDCS stimulator
Soterix Medicaltranscranial direct current stimulation
AstraZenecaValidation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale

Clinical Trials (5)

Total enrollment: 371 patients across 5 trials

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

Start: Jun 2010Est. completion: Jul 201731 patients
Phase 4Completed

Ketamine Infusion for Obsessive-Compulsive Disorder

Start: Feb 2009Est. completion: Dec 201110 patients
Phase 2Completed
NCT04781127Soterix MedicalSoterix Medical mini-CT tDCS stimulator

Home-administered tDCS for Treatment of Depression

Start: Feb 2021Est. completion: Aug 2022
Phase 1Completed
NCT07042217Soterix Medicaltranscranial direct current stimulation

Transcranial Direct Current Stimulation for Depression

Start: Jul 2025Est. completion: Sep 2026
N/ARecruiting
NCT01360307AstraZenecaValidation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale

Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale

Start: Jun 2011Est. completion: Nov 2011330 patients
N/ACompleted

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 371 patients
3 companies competing in this space